Skip to main content
Premium Trial:

Request an Annual Quote

Amy Pasquinelli,Jerome Groopman

Premium
The WM Keck Foundation announced this week the 2006 class of grant recipients under its distinguished young scholars in medical research program.
 
Among the winners is Amy Pasquinelli, a University of California, San Diego, researcher studying the role of microRNAs as regulators of biological pathways, as well as their role in cancer.
 
As a grant winner, Pasquinelli stands to receive up to $1 million to support her work over a five-year period.

Antisense drug developer Genta last week said that board member Jerome Groopman has resigned due to “personal health reasons.”
 
Groopman has served on Genta’s board since 2002.

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.